152 related articles for article (PubMed ID: 28457315)
1. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.
McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK
Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629
[TBL] [Abstract][Full Text] [Related]
3. Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins.
Wang L; Chen J; Sun Y; Zhang F; Zhu J; Hu S; Wang DH
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1146-53. PubMed ID: 16245407
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 attenuates the response to vascular injury.
Zimmerman MA; Reznikov LL; Raeburn CD; Selzman CH
J Surg Res; 2004 Oct; 121(2):206-13. PubMed ID: 15501460
[TBL] [Abstract][Full Text] [Related]
5. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
Soma MR; Donetti E; Parolini C; Mazzini G; Ferrari C; Fumagalli R; Paoletti R
Arterioscler Thromb; 1993 Apr; 13(4):571-8. PubMed ID: 8466892
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.
Horiuchi M; Cui TX; Li Z; Li JM; Nakagami H; Iwai M
Circulation; 2003 Jan; 107(1):106-12. PubMed ID: 12515751
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice.
Gervais M; Pons S; Nicoletti A; Cosson C; Giudicelli JF; Richer C
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):183-9. PubMed ID: 12588757
[TBL] [Abstract][Full Text] [Related]
8. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
9. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).
Hedblad B; Wikstrand J; Janzon L; Wedel H; Berglund G
Circulation; 2001 Apr; 103(13):1721-6. PubMed ID: 11282901
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies.
Qin F; Impeduglia T; Schaffer P; Dardik H
J Vasc Surg; 2003 Feb; 37(2):433-9. PubMed ID: 12563218
[TBL] [Abstract][Full Text] [Related]
11. Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury.
Zimmerman MA; Selzman CH; Reznikov LL; Miller SA; Raeburn CD; Emmick J; Meng X; Harken AH
Am J Physiol Regul Integr Comp Physiol; 2002 Aug; 283(2):R505-12. PubMed ID: 12121864
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin and clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model.
Bledsoe SL; Barr JC; Fitzgerald RT; Brown AT; Faas FH; Eidt JF; Moursi MM
Vasc Endovascular Surg; 2006; 40(1):49-57. PubMed ID: 16456606
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery.
Bandoh T; Mitani H; Niihashi M; Kusumi Y; Ishikawa J; Kimura M; Totsuka T; Sakurai I; Hayashi S
Eur J Pharmacol; 1996 Nov; 315(1):37-42. PubMed ID: 8960862
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis.
Muqri F; Helkin A; Maier KG; Gahtan V
J Cell Biochem; 2020 Oct; 121(10):4154-4165. PubMed ID: 32348623
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of plaque stabilization by fluvastatin with carotid intima- medial elasticity measured by a transcutaneous ultrasonic-based tissue characterization system.
Yamagishi T; Kato M; Koiwa Y; Omata K; Hasegawa H; Kanai H
J Atheroscler Thromb; 2009 Oct; 16(5):662-73. PubMed ID: 19907106
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
17. Rat strain determines statin effect on intimal hyperplasia after carotid balloon injury.
Helkin A; Desai P; Bailey I; Bruch D; Maier KG; Gahtan V
J Vasc Surg; 2016 Feb; 63(2):566-7. PubMed ID: 26804224
[No Abstract] [Full Text] [Related]
18. Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering.
Baetta R; Camera M; Comparato C; Altana C; Ezekowitz MD; Tremoli E
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):692-8. PubMed ID: 11950712
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement attenuates intimal hyperplasia development in an androgen deficient model of vascular injury.
Freeman BM; Univers J; Fisher RK; Kirkpatrick SS; Klein FA; Freeman MB; Mountain DJ; Grandas OH
J Surg Res; 2017 Jan; 207():53-62. PubMed ID: 27979488
[TBL] [Abstract][Full Text] [Related]
20. Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation.
Nakamura K; Sasaki T; Cheng XW; Iguchi A; Sato K; Kuzuya M
Atherosclerosis; 2009 Oct; 206(2):355-61. PubMed ID: 19296953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
